HAE

Haemonetics Corporation#66 · 2022EPB

Yearly return

+44%

Peak return

+58%

Max drawdown

-24%

ADR (20 days)

+2.9%

Base

19 days / -11.3%

Prior run

+46%

Breakout volume

2.8x

Pivot

$70.85

Catalyst Earnings/Guidance2022-08-10Haemonetics (HAE) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research

Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare HAE with the current market directly.